Herbig; Scott M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Herbig; Scott M..The latest application filed is for "solid pharmaceutical dispersions with enhanced bioavailability".

Company Profile

1.18.23

Herbig; Scott M. - East Lyme CT
Herbig; Scott M. - Groton CT
Herbig, Scott M - East Lyme CT
Herbig; Scott M. - Bend OR
Herbig; Scott M. - Deschutes OR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Solid Pharmaceutical Dispersions With Enhanced Bioavailability App 20150024054 - Curatolo; William J. ; et al.	2015-01-22
Solid Pharmaceutical Dispersions With Enhanced Bioavailability App 20130224301 - Curatolo; William J. ; et al.	2013-08-29
Solid pharmaceutical dispersions with enhanced bioavailability Grant 8,431,159 - Curatolo , et al. April 30, 2	2013-04-30
Solid pharmaceutical dispersions with enhanced bioavailability Grant 8,367,118 - Curatolo , et al. February 5, 2	2013-02-05
Solid Pharmaceutical Dispersions With Enhanced Bioavailability App 20120328679 - Curatolo; William J. ; et al.	2012-12-27
Solid pharmaceutical dispersions with enhanced bioavailability Grant 8,337,899 - Curatolo , et al. December 25, 2	2012-12-25
Solid Pharmaceutical Dispersions With Enhanced Bioavailability App 20120292797 - Curatolo; William J. ; et al.	2012-11-22
Solid Pharmaceutical Dispersions With Enhanced Bioavailability App 20120288542 - Curatolo; William J. ; et al.	2012-11-15
Solid pharmaceutical dispersions with enhanced bioavailability Grant 8,263,128 - Curatolo , et al. September 11, 2	2012-09-11
Solid pharmaceutical dispersions with enhanced bioavailability Grant 8,257,741 - Curatolo , et al. September 4, 2	2012-09-04
Multiparticulate crystalline drug compositions having controlled release profiles Grant 7,887,844 - Appel , et al. February 15, 2	2011-02-15
Dosage Forms Comprising Celecoxib Providing Both Rapid And Sustained Pain Relief App 20100233272 - Appel; Leah Elizabeth ; et al.	2010-09-16
Controlled release by extrusion of solid amorphous dispersions of drugs Grant 7,550,158 - Appel , et al. June 23, 2	2009-06-23
Controlled Release Dosage Forms Combining Immediate Release And Sustainted Release Of Low-solubility Drug App 20080299188 - Appel; Leah E. ; et al.	2008-12-04
Enteric Coated Azithromycin Multiparticulates App 20080199527 - Curatolo; William J. ; et al.	2008-08-21
Dosage Forms Providing Controlled and Immediate Release of Cholesteryl Ester Transfer Protein Inhibitors and Immediate Release of Hmg-Coa Reductase Inhibitors App 20080145427 - Berchielli; Alfred ; et al.	2008-06-19
Azithromycin Dosage Forms With Reduced Side Effects App 20080015343 - Hagen; Timothy A. ; et al.	2008-01-17
Azithromycin dosage forms with reduced side effects App 20060039988 - Hagen; Timothy A. ; et al.	2006-02-23
Azithromycin dosage forms with reduced side effects App 20060029677 - Hagen; Timothy A. ; et al.	2006-02-09
Azithromycin dosage forms with reduced side effects Grant 6,984,403 - Hagen , et al. January 10, 2	2006-01-10
Multiparticulate crystalline drug compositions having controlled release profiles App 20050181062 - Appel, Leah E. ; et al.	2005-08-18
Azithromycin multiparticulate dosage forms by melt-congeal processes App 20050158391 - Appel, Leah E. ; et al.	2005-07-21
Azithromycin dosage forms with reduced side effects App 20050123627 - Hagen, Timothy A. ; et al.	2005-06-09
Controlled release by extrusion of solid amorphous dispersions of drugs App 20040175428 - Appel, Leah E. ; et al.	2004-09-09
Controlled-Release of an active substance into a high fat environment App 20040121015 - Chidlaw, Mark B. ; et al.	2004-06-24
Sustained release formulations for growth hormone secretagogues App 20040091530 - Am Ende, Mary T. ; et al.	2004-05-13
Hydrogel-driven drug dosage form App 20040052845 - Appel, Leah E ; et al.	2004-03-18
Controlled release by extrusion of solid amorphous dispersions of drugs Grant 6,706,283 - Appel , et al. March 16, 2	2004-03-16
Solid pharmaceutical dispersions with enhanced bioavailability App 20030219489 - Curatolo, William J. ; et al.	2003-11-27
Sustained release formulations for growth hormone secretagogues Grant 6,641,840 - Am Ende , et al. November 4, 2	2003-11-04
Hydrogel-driven drug dosage form App 20030086972 - Appel, Leah E. ; et al.	2003-05-08
Sustained release formulations for growth hormone secretagogues App 20020137765 - Am Ende, Mary T. ; et al.	2002-09-26
Solid pharmaceutical dispersions with enhanced bioavailability App 20020009494 - Curatolo, William J. ; et al.	2002-01-24
Osmotic devices having vapor-permeable coatings Grant 5,827,538 - Cussler , et al. October 27, 1	1998-10-27
Osmotic-delivery devices having vapor-permeable coatings Grant 5,798,119 - Herbig , et al. August 25, 1	1998-08-25
Asymmetric membranes in delivery devices Grant 5,698,220 - Cardinal , et al. December 16, 1	1997-12-16
Use of asymmetric membranes in delivery devices Grant 5,612,059 - Cardinal , et al. March 18, 1	1997-03-18
Supported liquid membrane delivery devices Grant 5,603,953 - Herbig , et al. February 18, 1	1997-02-18
Adsorbents for the removal of volatile substances from aqueous systems Grant 5,091,080 - van Eikeren , et al. February 25, 1	1992-02-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.